Madrigal Pharmaceuticals ... (MDGL)
undefined
undefined%
At close: undefined
300.00
-0.81%
After-hours Dec 13, 2024, 06:41 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Net Income -373.63M -295.35M -241.85M -202.24M -83.95M -32.81M -31.15M -26.39M -68.67M -86.16M -90.19M -62.79M -47.38M -37.47M 79.09M -92.62M -63.49M -57.27M -68.86M -45.93M -27.88M
Depreciation & Amortization 527.00K 467.00K 405.00K 471.00K 112.00K 96.00K 77.00K 156.00 662.00K 673.00K 516.00K 738.00K 1.46M 1.93M 2.46M 2.72M 3.35M 3.65M 2.46M 1.55M 1.01M
Stock-Based Compensation 49.73M 31.63M 26.87M 20.73M 22.76M 13.49M 3.25M 8.68M 4.30M 7.43M 6.03M 3.32M 3.35M 4.05M 4.58M 7.57M 5.42M 4.79M - - -
Other Working Capital -7.49M 35.15M 10.29M 23.64M 20.76M -6.84M 4.59M 36.41M -5.89M 2.58M 5.31M 2.40M -6.28M -4.68M -113.57M 43.55M 82.09M -3.43M 266.00K 7.38M 866.00K
Other Non-Cash Items 2.41M 797.00K 7.32M 21.83M 24.29M 13.12M 2.49M 1.21M 3.48M 3.12K 6.03M - - - - 7.57M 5.42M 4.79M 4.26M 3.21M 2.39M
Deferred Income Tax - - -7.32M -21.83M -24.29M - - - - - -6.03M - - - - -7.57M -5.42M -4.79M - - -
Change in Working Capital -3.28M 37.60M 30.65M 23.48M 19.45M -6.28M 5.51M -1.11M -7.74M -868.00K 6.24M 4.59M -4.74M -6.71M -112.94M 44.39M 81.95M -4.16M 266.00K 7.38M 866.00K
Operating Cash Flow -324.23M -224.86M -183.92M -157.56M -41.62M -25.51M -22.32M -17.61M -71.44M -78.92M -77.41M -54.13M -47.30M -38.20M -26.81M -37.94M 27.22M -52.98M -61.88M -33.80M -23.61M
Capital Expenditures -1.48M -217.00K -209.00K -334.00K -172.00K -22.00K -125.00K -3.08K -58.00K -144.00K -769.00K -505.00K -690.00K -136.00K -454.00K -2.18M -2.35M -1.58M -4.88M -1.59M -769.00K
Acquisitions - -3.00K 787.00K 1.92M 3.65M -3.67M - 5.85M - 8.80K - 9.90K - 19.80K - - - - - - -
Purchase of Investments -834.44M -143.48M -394.12M -329.34M -619.30M -614.36M -70.21M -10.70M -117.14M -93.84M -114.15M -50.03M -50.73M -36.92M -39.30M -21.50M -15.01M -118.20M -184.37M -124.71M -47.92M
Sales Maturities Of Investments 333.40M 350.38M 389.27M 489.46M 650.18M 234.30M 48.33M 26.06M 137.19M 85.15M 90.27M 40.59M 60.74M 17.25M 60.81M - 28.15M 143.36M 228.42M 82.49M 7.79M
Other Investing Acitivies - 3.00K -787.00K -1.92M -3.65M 3.67M -21.88K 780.01K - -8.80K - -9.90K - -19.80K - - - - - - 500.00K
Investing Cash Flow -502.52M 206.69M -5.05M 159.78M 30.71M -380.08M -22.01M 21.99M 20.00M -8.84M -24.65M -9.94M 9.33M -19.80M 21.05M -23.69M 10.79M 23.57M 39.18M -43.81M -40.40M
Debt Repayment 65.00M 50.00M - - - - - 8.50M 3.30M -9.49M 10.87M -4.25M 1.42M 13.17M -2.18M -1.91M -2.62M -2.09M -1.10M -153.00K -70.00K
Common Stock Repurchased - - - - - - - - - - - -32.00K - - - - -290.00K - - - -
Dividend Paid - - - - - - - - - - - - - - - - - -1.86M - - -
Other Financial Acitivies 269.93M 8.07M 1.03M 667.00K 235.00K 2.51M - -250 - - - - - - - - 1.99M 3.27M 4.75M 1.13M -
Financial Cash Flow 595.12M 313.45M 171.24M 5.09M 235.00K 314.33M 173.81M 14.45M 40.39M 85.30M 69.04M 115.52M 36.74M 45.16M -2.13M -1.91M 43.88M 39.29M 3.78M 84.28M 71.12M
Net Cash Flow -231.63M 295.28M -17.73M 7.31M -10.68M -91.25M 129.48M 18.84M -11.06M -2.47M -33.02M 51.44M -1.24M -12.85M -7.89M -63.53M 81.89M 9.88M -18.93M 6.67M 7.11M
Free Cash Flow -325.71M -225.07M -184.13M -157.90M -41.80M -25.53M -22.44M -17.61M -71.50M -79.07M -78.18M -54.64M -47.99M -38.34M -27.26M -40.12M 24.87M -54.56M -66.77M -35.39M -24.38M